#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuronal ceroid lipofuscinosis Retinal dystrophy Vascular calcification Hypertriglyceridaemia Acute graft versus host disease in intestine Keratosis follicular Ureteric cancer Pleomorphic liposarcoma Pleural mesothelioma malignant Neurotrophic keratopathy Hereditary optic atrophy Paraneoplastic neurological syndrome Dermatomyositis Neurodermatitis Loss of consciousness More trials…

    Learn about Rare Diseases

    Vascular malformation – Treatment Stevens-Johnson syndrome – Life with Disease Hereditary ataxia – Treatment Mantle cell lymphoma stage II – Diagnostics Hepatic angiosarcoma – Treatment Marginal zone lymphoma – Diagnostics X-linked lymphoproliferative syndrome Mastocytosis Niemann-Pick disease – Treatment Atypical teratoid/rhabdoid tumour of CNS More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rasburicase Tapentadol Hydrochloride Omeprazole Aluminium Oxide, Hydrated Etelcalcetide Odm-208 M1P Dipotassium Salt Nanatinostat Sumatriptan Succinate Quc398 Eliglustat Tartrate Esk-001 Prednisolone Sodium Phosphate Rgx-202 Magnesium Hydroxide Abc-24F-116 Micronised Spironolactone Vobramitamab Duocarmazine Prednisone Acetate DNL593 More therapies…

    Learn about Your Condition

    Cholecystitis acute Hepatic angiosarcoma Juvenile spondyloarthritis Prostate cancer recurrent Hepatic cancer Metabolic disorder Kidney transplant rejection Skin angiosarcoma Colon cancer stage II Congenital aplastic anaemia Mucosal inflammation Mixed dementia Back pain Osteomyelitis acute Small fibre neuropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Rimonabant for Improving Walking Ability in Post‑Stroke Patients in the Chronic Phase

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Cerebrovascular accident
    Spain

  • Efficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Aflibercept
    Czechia Hungary Latvia Lithuania Poland Slovakia +1

  • Efficacy of Intravenous Lidocaine versus Sodium Chloride in Reducing Postoperative Pain for Patients Undergoing Emergency Abdominal Surgery

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Lidocaine Hydrochloride Monohydrate
    • Sodium Chloride
    France

  • Phase III Randomized Open‑Label Trial of BNT324 vs Docetaxel Plus Prednisone in Patients with Metastatic Castration‑Resistant Prostate Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Docetaxel
    • Prednisolone
    Belgium France Germany Hungary Italy Poland +1

  • Phase 1/2 Study Evaluating Safety and Activity of GSK5926371 in Adults with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Non-Hodgkin’s lymphoma
    Finland France Germany Italy Spain

  • Rituximab versus azathioprine for remission maintenance in patients with primary angiitis of the central nervous system – randomized controlled trial

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Azathioprine
    • Rituximab
    France
Previous Page
1 … 662 663 664 665 666 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!